Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucentis in Wet Age-related Macular Degeneration
NCT01810042Phase 4Completed
- Sponsor
- Pusan National University Hospital
- Start
- Oct 2010
- Primary completion
- Feb 2013
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in exudative macular degeneration, sponsored by Pusan National University Hospital. Started Oct 2010; status: completed.
02
Drugs
ranibizumab
03
Conditions
exudative macular degeneration
Beyond the preview
Go deeper on NCT01810042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01810042.